Two New European Patent Attorneys on the ZBM Team
We are delighted to announce that two of our team members Javier Ferrandis (MSc Control Systems and…
Read more
Back to Home
Protecting amino acid and nucleic acid sequence variants
The great success of biologics —drugs produced from living organisms or that contain components of living organisms— over the last…
Read more
How to improve (delay) the national/regional phase entry of a PCT application
The PCT application became a reality in 1978. In the same year it was also possible to apply for European…
Read more
Performance of ZBM Patents & Trademarks in opposition and appeal proceedings before the EPO
Since the work of oppositions and appeal in the European Patent Office (EPO) is highly specialized and challenging, we have…
Read more
“PCT DIRECT a great tool in patent prosecution strategy”
Many applicants file an international application (PCT) in the priority year to, among other reasons, delay the costs associated with…
Read more
Oral proceedings by videoconference at the EPO, are they here to stay?
The European patent opposition procedure is a fundamental tool to balance the interests of patent holders and third parties.
Most of…
Read more
ZBM listed among Europe’s leading patent law firms 2020 by Financial Times
ZBM Patents and Trademarks has obtained the Financial Times recognition as one of Europe’s Leading patent law firms 2020, particularly…
Read more
ZBM top firm in the IAM Patent 1000 Spain/EPO rankings 2020
We are delighted to announce that ZBM and their professionals stand out once again in the 2020 edition of the…
Read more
Montserrat Jané included in the Top 250 Women in IP 2020
We are proud to announce that the ZBM professionals are internationally recognized once more, particularly their female staff. After Anna…
Read more
Business as usual during spain’s lockdown for COVID-19
In view of the spread of Covid-19 in Spain, the government has now strongly restricted public activities and mobility in…
Read more